Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Drug usage/utilisation review (DUR)
Drug Utilization Reviews (DUR), also referred to as Drug Utilization Evaluations (DUE) is a pharmacoeconomic programme that reviews, analyses and interprets rates, costs and appropriateness of drug usage to assess inappropriate use, prevent adverse drug interactions and optimise appropriate use.
DURs involve a comprehensive review of patients' prescription and medication information before, during, and after dispense to ensure relevent medication decision making and positive patient outcomes.
See also:
Economic evaluation
Adverse reaction
Adherence
Concordance
Related terms
Persistence, Intent to treat, Toxicity, Control group, Competitors, Cost-effectiveness league table (healthcare economics), Fair balance, Payment by results (PBR) , British National Formulary (BNF), Regression analysis, Pre-clinical trials, Transfer price, Screening trials, Pharmaceutical Researchers and Manufacturers of America (PhRMA), Defined daily dose (DDD),
Subscribe to our email news alerts
Featured jobs
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- AstraZeneca joins UK pilot evaluating AI-based lung cancer diagnosis system
- Alzheimer’s Society urges UK government to deliver on dementia plan
- Amgen announces positive results for Lumakras colorectal cancer combination treatment
- BeiGene’s Brukinsa granted two new marketing authorisations by MHRA
- Europe’s cancer community publishes new report on transforming patient care
- Alzheimer’s Research UK welcomes government’s pledge to tackle dementia crisis
- Eli Lilly announces $450m investment in US manufacturing site
- Pistoia Alliance launches free guide on implementing FAIR principles in clinical data
- World Health Organization launches $2.54bn emergency health appeal
- EU outlines measures to mitigate antibiotic shortage across Europe
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- EU to revise pharmaceuticals law amid antibiotic shortages
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Why everyone in pharma is bending over backwards to be agile
PMHub
Fishawack Health
Established in 2001, Fishawack Health (FH) is a purposefully built commercialization partner for the biopharmaceutical, medical technology, and wellness industries....
